Interferon alfacon-1
From Wikipedia, the free encyclopedia
Jump to navigation
Jump to search
Interferon alfacon-1Clinical data |
---|
Pregnancy category |
US: C (Risk not ruled out)
|
---|
Routes of administration |
Parenteral |
---|
ATC code |
|
---|
Legal status |
---|
Legal status |
|
---|
Identifiers |
---|
CAS Number |
118390-30-0 Y
|
---|
DrugBank |
DB00069 N
|
---|
ChemSpider |
|
---|
Chemical and physical data |
---|
Formula |
C860H1353N227O255S9 |
---|
Molar mass |
19343 g/mol |
---|
NY (what is this?) (verify)
|
---|
Interferon alfacon-1 is a recombinant synthetic type I interferon used for the treatment of hairy cell leukemia, malignant melanoma and AIDS-related Kaposi's sarcoma.[1]
References[edit]
Immunostimulants (L03)
|
---|
Endogenous |
Cytokines |
Colony-stimulating factors |
G-CSF
Filgrastim / Pegfilgrastim
- Lenograstim
GM-CSF
SCF
|
---|
Interferons |
alpha:
- Albinterferon
Interferon alfa natural
Interferon alfa 2a / Peginterferon alfa-2a
Interferon alfa 2b / Peginterferon alfa-2b
- Interferon alfa n1
- Interferon alfacon-1
- Interferon alpha-n3
beta:
Interferon beta natural
- Interferon beta 1a
- Interferon beta 1b
- Interferon gamma
|
---|
Interleukins |
|
---|
|
---|
Other protein / peptide |
- Growth hormone
- Immunocyanin
- Pegademase
- Prolactin
- Tasonermin
|
---|
Other |
- Female sex steroids
- Histamine dihydrochloride
- Poly ICLC
- Vitamin D
|
---|
|
---|
Exogenous |
beta-glucan
heterocyclic compound
hydroxyquinoline
- Mifamurtide
oligopeptides
- Glatiramer acetate
- Thymopentin
- Thymosin α1
- Thymulin
polyribonucleotide
- Polyinosinic:polycytidylic acid
thiazolidine
vaccines
- Bacillus Calmette–Guérin
- Melanoma vaccine
- Sipuleucel-T
|
---|
Cytokine receptor modulators
|
---|
Chemokine |
|
---|
CSF |
Erythropoietin |
Agonists: ARA-290
- Asialo erythropoietin
- Carbamylated erythropoietin
- CNTO-530
- Darbepoetin alfa
- Epoetin alfa
- Epoetin beta
- Epoetin delta
- Epoetin epsilon
- Epoetin gamma
- Epoetin kappa
- Epoetin omega
- Epoetin theta
- Epoetin zeta
- Erythropoietin (EPO)
- Erythropoietin-Fc
- Methoxy polyethylene glycol-epoetin beta (CERA/Mircera)
- Peginesatide
- Pegol sihematide (EPO-018B)
|
---|
G-CSF (CSF3) |
Agonists: Filgrastim
- Granulocyte colony-stimulating factor
- Lenograstim
- Leridistim
- Lipegfilgrastim
- Nartograstim
- Pegfilgrastim
- Pegnartograstim
|
---|
GM-CSF (CSF2) |
Agonists: Ecogramostim
- Granulocyte macrophage colony-stimulating factor
- Milodistim
- Molgramostim
- Regramostim
- Sargramostim
Antibodies: Mavrilimumab
- MOR103
- Namilumab
|
---|
M-CSF (CSF1) |
Agonists: Cilmostim
- Interleukin-34
- Lanimostim
- Macrophage colony-stimulating factor
- Mirimostim
Kinase inhibitors: Agerafenib
|
---|
SCF (c-Kit) |
|
---|
Thrombopoietin |
Agonists: Eltrombopag
- Pegacaristim
- Promegapoietin
- Romiplostim
- Thrombopoietin (THPO, MGDF)
|
---|
|
---|
Interferon |
IFNAR (α/β, I) |
Agonists: Albinterferon
- Interferon alpha (interferon alfa, IFN-α)
Interferon alfa (IFNA1, IFNA2, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA21)
- Interferon alfa 2a
- Interferon alfa 2b
- Interferon alfa n1
- Interferon alfacon-1
- Interferon alpha-n3
Interferon beta (IFN-β) (IFNB1, IFNB3)
- Interferon beta 1a
- Interferon beta 1b
- Interferon kappa (IFN-ε/κ/τ/ζ, IFNK)
- Interferon omega (IFN-ω, IFNW1)
- Peginterferon alfa-2a
- Peginterferon alfa-2b
Antibodies: Anifrolumab
- Faralimomab
- MEDI-545
- Rontalizumab
- Sifalimumab
Decoy receptors: Bifarcept
|
---|
IFNGR (γ, II) |
Agonists: Interferon gamma (IFN-γ)
- Interferon gamma 1b
Antibodies: Emapalumab
- Fontolizumab
|
---|
IFNLR (λ, III) |
- See IL-28R (IFNLR) here instead.
|
---|
|
---|
Interleukin |
|
---|
TGFβ |
|
---|
TNF |
|
---|
Others |
JAK (inhibitors)
|
JAK1 |
- Baricitinib
- Filgotinib
- Momelotinib
- Oclacitinib
- Ruxolitinib
- Tofacitinib (tasocitinib, CP-690550)
- Upadacitinib
|
---|
JAK2 |
- AG-490
- Atiprimod
- AZD-1480
- Baricitinib
- CHZ868
- Cucurbitacin I (elatericin B, JSI-124)
- CYT387
- Lestaurtinib
- NSC-7908
- NSC-33994
- Pacritinib
- Ruxolitinib
- SD-1008
- Tofacitinib (tasocitinib, CP-690550)
|
---|
JAK3 |
- AG-490
- Cercosporamide
- TCS-21311
- Tofacitinib (tasocitinib, CP-690550)
- WHI-P 154
- ZM-39923
- ZM-449829
|
---|
|
---|
Others |
Additional cytokines: Cardiotrophin 1 (CT-1)
- FMS-like tyrosine kinase 3 ligand (FLT3L)
- Leukemia/leukocyte inhibitory factor (LIF)
- Oncostatin M (OSM)
- Thymic stromal lymphopoietin (TSLP)
Additional cytokine receptor modulators: Emfilermin
- Lestaurtinib
- Midostaurin
- Quizartinib
- Sorafenib
- Sunitinib
|
---|
|
---|
- See also
- Receptor/signaling modulators
- Signaling peptide/protein receptor modulators
- Growth factor receptor modulators
|
Categories:
- Immunostimulants
- Antivirals
- Antineoplastic and immunomodulating drug stubs
Hidden categories:
- Articles with changed DrugBank identifier
- Chemicals that do not have a ChemSpider ID assigned
- Infobox drug articles without a structure image
- Articles without EBI source
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugboxes which contain changes to verified fields
- All stub articles
Navigation menu
Personal tools
- Not logged in
- Talk
- Contributions
- Create account
- Log in
Navigation
- Main page
- Contents
- Featured content
- Current events
- Random article
- Donate to Wikipedia
- Wikipedia store
Interaction
- Help
- About Wikipedia
- Community portal
- Recent changes
- Contact page
Tools
- What links here
- Related changes
- Upload file
- Special pages
- Permanent link
- Page information
- Wikidata item
- Cite this page
Print/export
- Create a book
- Download as PDF
- Printable version
Languages
- Српски / srpski
- Srpskohrvatski / српскохрватски
Edit links
(window.RLQ=window.RLQ||).push(function()mw.config.set("wgPageParseReport":"limitreport":"cputime":"0.444","walltime":"0.548","ppvisitednodes":"value":4534,"limit":1000000,"ppgeneratednodes":"value":0,"limit":1500000,"postexpandincludesize":"value":106236,"limit":2097152,"templateargumentsize":"value":2585,"limit":2097152,"expansiondepth":"value":16,"limit":40,"expensivefunctioncount":"value":1,"limit":500,"unstrip-depth":"value":0,"limit":20,"unstrip-size":"value":488,"limit":5000000,"entityaccesscount":"value":1,"limit":400,"timingprofile":["100.00% 434.705 1 -total"," 86.20% 374.708 1 Template:Drugbox"," 56.55% 245.829 1 Template:Infobox"," 17.41% 75.683 16 Template:Unbulleted_list"," 12.96% 56.353 8 Template:Navbox"," 10.27% 44.647 1 Template:Infobox_drug/chemical_formula"," 5.40% 23.473 1 Template:Cytokine_receptor_modulators"," 4.70% 20.413 1 Template:Infobox_drug/maintenance_categories"," 4.16% 18.068 1 Template:Immunostimulants"," 3.16% 13.742 4 Template:Main_other"],"scribunto":"limitreport-timeusage":"value":"0.134","limit":"10.000","limitreport-memusage":"value":2090378,"limit":52428800,"cachereport":"origin":"mw1254","timestamp":"20181010180843","ttl":1900800,"transientcontent":false);mw.config.set("wgBackendResponseTime":73,"wgHostname":"mw1274"););